Form 4 for PASG Passage BIO, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-31 · accession 0001209191-24-000367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2024-01-02 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.91 | -10.7K | 25.9K | -29% | -$9,712 |
| D | 2024-01-03 | 2023-12-31 | PASG | Borthwick Kathleen | SVP, Interim CFO | M - OptEx | — | +30.0K | 36.6K | +454% | — |
| D | 2024-01-03 | 2023-12-31 | PASG | Borthwick Kathleen | SVP, Interim CFO | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 10,672 | $0.91 | 25,936 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-31 | M | A | 30,000 | — | 36,608 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F2) Includes 3,082 shares acquired on May 13, 2022 and 3,526 shares acquired on November 15, 2023 under the 2020 Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Unit | 2023-12-31 | M | D | 30,000 | $0.00 | 0 | D | — · — to — | 30,000 Common Stock | (F4) Each RSU represents a contingent right to receive one share of Issuer's common stock. (F5) 100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |